Roivant Sciences Ltd

NASDAQ:ROIV   4:00:00 PM EDT
6.33
+0.15 (+2.43%)
7:03:27 PM EDT: $6.25 -0.08 (-1.26%)
Earnings Announcements

Roivant Sciences Reports Financial Results For Q2

Published: 11/14/2022 13:17 GMT
Roivant Sciences Ltd (ROIV) - Roivant Sciences Reports Financial Results for the Second Quarter Ended September 30, 2022 and Provides Business Update.
Expected Cash Runway Extended Into Second Half of Calendar Year 2025.
On a per Common Share Basis, Net Loss Was $0.42 for Three Months Ended September 30.
Q2 Earnings per Share View $-0.42 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $13.26 Million
Adjusted EPS is expected to be -$0.35

Next Quarter Revenue Guidance is expected to be $17.45 Million
Next Quarter EPS Guidance is expected to be -$0.36

More details on our Analysts Page.